Drug Reference

Osimertinib

Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

← All medicines · Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors

Fact box

Therapeutic class
Epidermal growth factor receptor (EGFR) tyrosine kinase inhibitors
Action class
Kinase Inhibitor
Mechanism
Kinase Inhibitors
Habit forming
No

Brand names

Tagrisso

Available as

40 MG · Oral Tablet80 MG · Oral Tablet

No structured FDA label was available. Use the authoritative links below.

Current FDA labels (DailyMed)

4 marketed products on record (RxNorm)

Authoritative sources

Reference only — not clinical advice. Verify against current FDA labeling and consult a licensed provider. About half of pediatric drug use is off-label and is not reflected in FDA labels; absence of pediatric information does not mean a medicine is unused or unsafe in children.